Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis-Reference-Cited by-同舟云学术

Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

Published:2022-04 Issue:4 Volume:24 Page:554-564
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Zhang Yun^ORCID,Donaher Joana Liu,Das Sunny,Li Xin,Reinhardt Ferenc,Krall Jordan A.,Lambert Arthur W.,Thiru Prathapan,Keys Heather R.^ORCID,Khan Mehreen,Hofree Matan,Wilson Molly M.,Yedier-Bayram Ozlem,Lack Nathan A.,Onder Tamer T.^ORCID,Bagci-Onder Tugba^ORCID,Tyler Michael^ORCID,Tirosh Itay^ORCID,Regev Aviv^ORCID,Lees Jacqueline A.^ORCID,Weinberg Robert A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

https://www.nature.com/articles/s41556-022-00877-0.pdf

Reference67 articles.

1. Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).

2. Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).

3. Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611–1624 (2017).

4. McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present and the future. Cell 168, 613–628 (2017).

5. Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328–337 (2013).

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cells;Cell Death & Disease;2024-08-22

2. Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition;Proceedings of the National Academy of Sciences;2024-08-02

3. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets;MedComm;2024-08

4. Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning;2024-06-29

5. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27